HMGB1 and cholesteatoma: Measuring the levels of HMGB1 in lysed sEVs by ELISA revealed a statistically significant different when comparing cholesteatoma patient-derived sEVs and sEVs isolated from normal controls (p < 0.05; Figure 2D).